Thailand Nares Damrongchai has been the CEO of the Thailand Center of Excellence for Life Science (TCELS) since its foundation in 2004. After seven years onboard, he discusses the organization’s progress in attracting more biotech investment to Thailand and the challenges he has faced along the way. [Our mission is]…
China Dr. Zhengyu Yuan, president & CEO of MicuRx, shares the story of how MicuRx was founded in 2007 to develop new and innovative antimicrobial drugs; their flagship product, contezolid, which recently concluded Phase III trials in China; and their future plans for an IPO. We combined US experience and…
Sweden Swedish Labtech is an industry organization for companies involved in laboratory activities. Chairman Peter Simonsbacka discusses the challenges facing the life science industry, the opportunity to bring back the strong clinical trials tradition in the country and the unique Swedish collaborative ecosystem. Sweden has a very open environment when…
Thailand Sayan Roy, managing director of B. Braun Thailand, highlights the importance of the group’s 2020 Vision “Growing Together” and how the affiliate is carrying this out locally to be a partner of Thailand’s healthcare system. Sayan goes on to elaborate on B. Braun’s commitment to bringing full solutions based on…
Sweden Michelle Werner, country president for AstraZeneca’s Nordics and Baltics region, highlights the company’s strong connections with local stakeholders due to its historic roots and large footprint in Sweden. Werner also discusses how the organization, which employs nearly 7,000 people in the country, plays an integral part in ensuring that patients…
China The meteoric growth of the pharmaceutical industry in China in recent years has seen a host of top Chinese talent return home from studying and working overseas to establish their own firms. Dubbed ‘Sea Turtles’ (‘海龟’ haigui), as ‘海’ (hai) means ‘ocean’ in Chinese and ‘龟’ (gui) is a homonym…
Opinion Sophia Ononye outlines the history of cannabis as a medicine in the US and, following the first FDA approval of a cannabis-derived drug product in 2018, the highly promising landscape for further approvals. The landscape for approved CBD products is highly promising and will undoubtedly lead to additional FDA…
Algeria Yacine Sellam examines how pharmacists in Algeria can follow the lead of their US counterparts and play a greater role in patients’ diabetes management. Noncommunicable diseases are a growing burden in Algeria. The results of a STEPwise survey revealed that, for adults aged between 18 and 69 years, 23.6…
Taiwan United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and infectious diseases and is passionate about delivering science-driven innovation with platform capabilities. Chang Yi Wang is the Chairperson and CSO of United BioPharma (UBP), a member of the UBI group of…
Pharma Faces 2019 saw Boehringer Ingelheim (BI) veteran Felix Gutsche take up his first country manager role – of a top-three affiliate, no less – after blazing a rather unorthodox path. From an International Trainee role at BI HQ, he moved into finance, where he stayed for a decade, with stints in…
Taiwan James Chiu, GM of Fresenius Kabi Taiwan, discusses the affiliate’s portfolio offering of parenteral and enteral nutrition in Taiwan as well as its move towards biosimilars. In addition, Chiu highlights the importance of the Taiwanese affiliate to the Asia Pacific region, product developments locally, and partnerships with domestic players. …
Sweden Grifols is a pioneer in plasma science that develops plasma into essential medicines used to treat rare, chronic and life-threatening conditions. Eric Björnestål, general manager for the Nordic region, explains how the company is leveraging its knowledge of the public tender process to continue to grow in the region, highlights…
See our Cookie Privacy Policy Here